One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Human Epidermal Growth Factor Receptor 2-Mutant Non-Small-Cell Lung Cancer: Continued Progress But Challenges Remain.
Cooper, Alissa J. MD 1; Gainor, Justin F. MD 1,,
doi : 10.1200/JCO.21.02550
Volume 40(7) pgs. 693-806 March 1, 2022
Response-Adapted Therapy in Follicular Lymphoma: At the Threshold of a Precision Approach.
Casulo, Carla MD 1,,
doi : 10.1200/JCO.21.02477
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.
Elamin, Yasir Y. MD 1,; Robichaux, Jacqulyne P. PhD 1,; Carter, Brett W. MD 2; Altan, Mehmet MD 1,; Gibbons, Don L. MD, PhD 1,; Fossella, Frank V. MD 1; Lam, Vincent K. MD 1,3,; Patel, Anisha B. MD 4,; Negrao, Marcelo V. MD 1,; Le, Xiuning MD, PhD 1,; Mott, Frank E. MD 1; Zhang, Jianjun MD, PhD 1,; Feng, Lei PhD 5; Blumenschein, George Jr MD 1,; Tsao, Anne S. MD 1,; Heymach, John V. MD, PhD 1,,
doi : 10.1200/JCO.21.01113
Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial.
Le, Xiuning MD, PhD 1,; Cornelissen, Robin MD, PhD 2,; Garassino, Marina MD 3,; Clarke, Jeffrey M. MD 4,; Tchekmedyian, Nishan MD 5,; Goldman, Jonathan W. MD 6,; Leu, Szu-Yun PhD 7,; Bhat, Gajanan PhD 7,; Lebel, Francois MD 7,; Heymach, John V. MD, PhD 1,; Socinski, Mark A. MD 8,,
doi : 10.1200/JCO.21.01323
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial.
Mazieres, Julien MD, PhD 1,,; Lafitte, Claire MD 2; Ricordel, Charles MD 3,; Greillier, Laurent MD, PhD 4,; Negre, Elodie MD 5; Zalcman, Gerard MD, PhD 6,; Domblides, Charlotte MD, PhD 7,; Madelaine, Jeannick MD 8,; Bennouna, Jaafar MD, PhD 9,; Mascaux, Celine MD, PhD 10,; Moro-Sibilot, Denis MD, PhD 11,; Pinquie, Francois MD 12,; Cortot, Alexis B. MD, PhD 13,; Otto, Josiane MD 14; Cadranel, Jacques MD, PhD 15,; Langlais, Alexandra MSc 16; Morin, Franck MSc 17; Westeel, Virginie MD, PhD 18,; Besse, Benjamin MD, PhD 19,
doi : 10.1200/JCO.21.01455
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study.
Luminari, Stefano MD 1,2,,; Manni, Martina MD 1; Galimberti, Sara MD 3,; Versari, Annibale MD 4,; Tucci, Alessandra MD 5,; Boccomini, Carola MD 6; Farina, Lucia MD 7; Olivieri, Jacopo MD 8; Marcheselli, Luigi MSc 9,; Guerra, Luca MD 10,11; Ferrero, Simone MD 12,; Arcaini, Luca MD 13,; Cavallo, Federica MD 12,; Kovalchuk, Sofya MD 14; Skrypets, Tetiana MD 1,15,; del Giudice, Ilaria MD 16,; Chauvie, Stephane MD 17,; Patti, Caterina MD 18; Stelitano, Caterina MD 19; Ricci, Francesca MD 20; Pinto, Antonello MD 21,; Margiotta Casaluci, Gloria MD 22; Zilioli, Vittorio R. MD 23; Merli, Anna MD 24; Ladetto, Marco MD 25,26,; Bolis, Silvia MD 27; Pavone, Vincenzo MD 28; Chiarenza, Annalisa MD 29,; Arcari, Annalisa MD 30,; Anastasia, Antonella MD 5; Dondi, Alessandra PhD 9; Mannina, Donato MD 31; Federico, Massimo MD 1,; on behalf of Fondazione Italiana Linfomi
doi : 10.1200/JCO.21.01234
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
Cheng, En MD, PhD 1,2,; Ou, Fang-Shu PhD 3,; Ma, Chao MS 4; Spiegelman, Donna ScD 5,6; Zhang, Sui MS 4; Zhou, Xin PhD 5,6; Bainter, Tiffany M. MPH 3; Saltz, Leonard B. MD 7,; Niedzwiecki, Donna PhD 8; Mayer, Robert J. MD 4,; Whittom, Renaud MD 9,; Hantel, Alexander MD 10; Benson, Al MD 11,; Atienza, Daniel MD 12,; Messino, Michael MD 13; Kindler, Hedy MD 14,; Giovannucci, Edward L. MD, DrPH 15; Van Blarigan, Erin L. ScD 16; Brown, Justin C. PhD 17; Ng, Kimmie MD, MPH 4,; Gross, Cary P. MD 1,18,19,; Meyerhardt, Jeffrey A. MD, MPH 4,; Fuchs, Charles S. MD, MPH 1,20,21,22,,
doi : 10.1200/JCO.21.01784
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.
O'Malley, David M. MD 1,,; Bariani, Giovanni Mendonca MD 2,; Cassier, Philippe A. MD 3,; Marabelle, Aurelien MD, PhD 4,; Hansen, Aaron R. MBBS 5,; De Jesus Acosta, Ana MD 6,; Miller, Wilson H. Jr MD, PhD 7,8,; Safra, Tamar MD 9,10; Italiano, Antoine MD, PhD 11,12,; Mileshkin, Linda MBBS 13; Xu, Lei PhD 14,; Jin, Fan MD 14,; Norwood, Kevin MD 14,; Maio, Michele MD 15,
doi : 10.1200/JCO.21.01874
Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study.
O'Malley, David M. MD 1,,; Neffa, Maryna MD, PhD 2; Monk, Bradley J. MD 3,; Melkadze, Tamar MD 4; Huang, Marilyn MD 5,; Kryzhanivska, Anna MD 6; Bulat, Iurie MD, PhD 7; Meniawy, Tarek M. MD 8,; Bagameri, Andrea MD 9; Wang, Edward W. MD, PhD 10; Doger de Speville Uribe, Bernard MD, PhD 11; Hegg, Roberto MD 12; Ortuzar Feliu, Waldo MD 13,; Ancukiewicz, Marek PhD 13,; Lugowska, Iwona MD, PhD 14,
doi : 10.1200/JCO.21.02067
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation.
Elsayed, Abdelrahman H. PhD 1,; Cao, Xueyuan PhD 2; Mitra, Amit K. PhD 3; Wu, Huiyun PhD 4; Raimondi, Susana PhD 5; Cogle, Christopher MD, PhD 6,; Al-Mansour, Zeina MD 6; Ribeiro, Raul C. MD 7; Gamis, Alan MD 8,; Kolb, Edward Anders MD 9,; Aplenc, Richard MD, PhD 10,; Alonzo, Todd A. PhD 11,12; Meshinchi, Soheil MD, PhD 13; Rubnitz, Jeffrey MD, PhD 7,; Pounds, Stanley PhD 4,; Lamba, Jatinder K. PhD 1,14,15,,
doi : 10.1200/JCO.21.01422
Toward Personalization of Cytarabine Dosing in Acute Myeloid Leukemia.
Jordheim, Lars Petter PharmD, PhD 1,
doi : 10.1200/JCO.21.02723
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
Eisen, Andrea MD 1,; Somerfield, Mark R. PhD 2; Accordino, Melissa K. MD 3,; Blanchette, Phillip S. MD 4; Clemons, Mark J. MD 5,; Dhesy-Thind, Sukhbinder MD 6,; Dillmon, Melissa S. MD 7,; D'Oronzo, Stella MD, PhD 8; Fletcher, Glenn G. MSc 9; Frank, Elizabeth S. EdM 10,; Hallmeyer, Sigrun MD 11,; Makhoul, Issam MD 12; Moy, Beverly MD 13,; Thawer, Alia MD 1,; Wu, Joy Y. MD, PhD 14,; Van Poznak, Catherine H. MD 15,
doi : 10.1200/JCO.21.02647
JCOG0603: Are We Really Sure This Was a Negative Trial?.
Saude Conde, Rita MD; Bregni, Giacomo MD; Saad, Everardo MD; Hendlisz, Alain MD, PhD; Sclafani, Francesco MD, PhD
doi : 10.1200/JCO.21.02299
